Vifor Pharma (United States)
CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma and Sanifit Therapeutics. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vifor Pharma (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
57%
Total
Publications
150
Total Open
Publications
86
Total
Citations
3.7K
Open Access
Percentage
57%
Total
Publications
150
Total Open
Publications
86
Total
Citations
3.7K
Breakdown
Publisher Open
19%
Both
29%
Other Platform Open
10%
Closed
42%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 39%
28
Hybrid 27%
19
No Guarantees 34%
24
Other Platform Open
Domain 84%
49
Institution 19%
11
Preprint 10%
6
Other Internet 7%
4
Public 5%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 49 |
Europe PMC | Domain | 23 |
University College London - UCL Discovery | Institution | 6 |
Research Square | Preprint | 5 |
University of Michigan - Deep Blue | Institution | 2 |
Semantic Scholar | Public | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Inria | Institution | 2 |
California Digital Library - eScholarship | Other Internet | 2 |
University of Zurich - Zurich Open Repository and Archive | Institution | 1 |
University of Southern Denmark - University of Southern Denmark Research Portal | Institution | 1 |